fingolimod hydrochloride has been researched along with Astrocytosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bielawski, J; Kim, S; Kong, Y; Li, J; Yang, H; Zhou, B | 1 |
| Chen, Y; Dong, S; Tan, X; Yan, B; Yang, Z; Zhang, L; Zheng, Q; Zou, J | 1 |
| Brunkhorst, R; Derouiche, A; Ferreirós, N; Foerch, C; Kanaan, N; Koch, A; Mirceska, A; Mittelbronn, M; Pfeilschifter, J; Pfeilschifter, W; Steinmetz, H; Zeiner, P | 1 |
| Cai, Y; Heng, BC; Hong, L; Liu, H; Lu, P; Ouyang, H; Ren, H; Wang, J; Wang, Y; Zhou, J | 1 |
| Furusawa, E; Irisa, M; Itoh, K; Kaizu, K; Kodama, T; Ogawa, Y; Oishi, K; Saito, T; Sakuraba, H; Sano, T; Togawa, T; Tsukimura, T; Yamanaka, S; Yanagi, Y | 1 |
5 other study(ies) available for fingolimod hydrochloride and Astrocytosis
| Article | Year |
|---|---|
Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
Topics: Animals; Apoptosis; Brain; Chimera; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Fingolimod Hydrochloride; Gene Expression; Gliosis; Indans; Inflammation; Male; Mice, Inbred C57BL; Mice, Transgenic; Neuroglia; Neuroprotective Agents; Oxadiazoles; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors; White Matter | 2018 |
FTY720 attenuates iron deposition and glial responses in improving delayed lesion and long-term outcomes of collagenase-induced intracerebral hemorrhage.
Topics: Animals; Brain; Brain Injuries; Cerebral Hemorrhage; Disease Models, Animal; Fingolimod Hydrochloride; Gliosis; Inflammation; Iron; Male; Mice; Mice, Inbred ICR; Neuroglia; Neuroprotective Agents | 2019 |
FTY720 treatment in the convalescence period improves functional recovery and reduces reactive astrogliosis in photothrombotic stroke.
Topics: Aldehyde-Lyases; Animals; Astrocytes; Cerebral Cortex; Convalescence; Fingolimod Hydrochloride; Gene Expression; Gliosis; Immunosuppressive Agents; Intracranial Thrombosis; Male; Mice; Mice, Inbred C57BL; Post-Synaptic Density; Propylene Glycols; Recovery of Function; Reverse Transcriptase Polymerase Chain Reaction; Sphingosine; Stroke; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A | 2013 |
Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis.
Topics: Administration, Topical; Animals; Delayed-Action Preparations; Fingolimod Hydrochloride; Gliosis; Immunosuppressive Agents; Lysophospholipids; Male; Membranes, Artificial; Polyesters; Rats; Rats, Sprague-Dawley; Recovery of Function; Sphingosine; Spinal Cord Injuries; Treatment Outcome | 2015 |
FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice.
Topics: Animals; Astrocytes; beta-Hexosaminidase beta Chain; Cerebral Cortex; Disease Models, Animal; Fingolimod Hydrochloride; G(M2) Ganglioside; Gliosis; Heterozygote; Immunity; Immunosuppressive Agents; Mice, Inbred C57BL; Motor Activity; Phenotype; Receptors, Fc; Sandhoff Disease; Up-Regulation; Walking | 2017 |